Dieter Ziegler

Title: Dieter Ziegler: Innovator in Neurodegenerative Disorder Treatments

Introduction

Dieter Ziegler is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative disorders. His innovative work has led to the development of important therapeutic compounds.

Latest Patents

Dieter Ziegler holds a patent for "Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders." This invention relates to a novel use of known benzazepine, benzoxazepine, benzo-thiazepine-N-acetic acid, and phosphono-substituted benzazepinone derivatives that exhibit NEP and/or hSEP inhibitory activity. The compounds are useful for preparing pharmaceutical compositions aimed at preventing and treating neurodegenerative disorders. His patent is documented under the European patents EP 0 733 642 and EP 0 916 679.

Career Highlights

Dieter Ziegler is associated with Solvay Pharmaceuticals B.V., where he has contributed to various research initiatives. His work focuses on developing innovative solutions for complex medical challenges.

Collaborations

Dieter has collaborated with notable colleagues, including Lechoslaw A Turski and Hrissanthi Ikonomidou. These collaborations have further enhanced the research and development efforts in the field of neurodegenerative disorders.

Conclusion

Dieter Ziegler's contributions to the pharmaceutical industry, particularly in neurodegenerative disorder treatments, highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in medical science.